MTOR and glioma: Importantly, PI3K/AKT/mTOR is critical to maintaining the CSC population in various cancers, including nasopharyngeal carcinoma,209 glioma,210 pancreatic cancer,211 lung cancer,212 prostate,213 and breast cancer.214